NasdaqGS:IMCRBiotechs
Assessing Immunocore Holdings (IMCR) Valuation After R&D Leadership Restructure
Immunocore Holdings (IMCR) has reshaped its senior leadership after announcing the planned departure of Executive Vice President of Research and Development Dr. David Berman, and is shifting responsibility across its existing research, clinical, and regulatory heads.
See our latest analysis for Immunocore Holdings.
The leadership reshuffle comes as Immunocore’s share price sits at US$32.93, with a 7 day share price return of 4.54% but a 90 day share price return decline of 6.90%, while the 1...